Correlation Between Cingulate Warrants and Pasithea Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cingulate Warrants and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Cingulate Warrants and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Pasithea Therapeutics.

Diversification Opportunities for Cingulate Warrants and Pasithea Therapeutics

0.77

Correlation Coefficient

Cingulate Warrants  Pasithea Therapeutics

Poor diversification

The 3 months correlation between Cingulate and Pasithea is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Pasithea Therapeutics go up and down completely randomly.

Pair Corralation between Cingulate Warrants and Pasithea Therapeutics

Assuming the 90 days horizon Cingulate Warrants is expected to generate 1.82 times more return on investment than Pasithea Therapeutics. However, Cingulate Warrants is 1.82 times more volatile than Pasithea Therapeutics Corp. It trades about 0.06 of its potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.02 per unit of risk. If you would invest  5.77  in Cingulate Warrants on September 5, 2024 and sell it today you would lose (0.92) from holding Cingulate Warrants or give up 15.94% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.44%
Values	Daily Returns

Cingulate Warrants  vs.  Pasithea Therapeutics Corp

Cingulate Warrants

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cingulate Warrants are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Cingulate Warrants showed solid returns over the last few months and may actually be approaching a breakup point.

Pasithea Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pasithea Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Cingulate Warrants and Pasithea Therapeutics

The main advantage of trading using opposite Cingulate Warrants and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.

The idea behind Cingulate Warrants and Pasithea Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.